|
WASHINGTON, June 4 (Reuters) - U.S. health officials are investigating whether drugs for rheumatoid arthritis and Crohn's disease are linked to cancers in children and young adults, the Food and Drug Administration said on Wednesday.
The prescription drugs, members of a family called TNF blockers, include Johnson & Johnson's Remicade, Abbott Laboratories Inc's Humira, and Amgen Inc and Wyeth's Enbrel.
The FDA said it was probing about 30 reports of cancer in children and young adults treated with TNF blockers plus other immune-suppressing medicines between 1998 and April 29, 2008. About half of the cancers were lymphomas.
More
http://www.reuters.com/article/governmentFilingsNews/idUSN0431255120080604
|